EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Trends in dual antiplatelet therapy regimens and clinical outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention with drug‐eluting stents: A multicenter real‐world study

Preyanate Wilairat iD, Arintaya Phrommintikul iD, Thanyalak Chotayaporn, Supharat Wattanasombat iD, Rungtiwa Hmuenpha, Supitchaya Kornjirakasemsan, Duangkamon Poolpun iD, Voratima Yoodee iD

Chronic Diseases and Translational Medicine · 2025-03 · 11 (1) · 57-68

DOI: 10.1002/cdt3.154 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chronic Diseases and Translational Medicine, online erschienen am 14.11.2024. Verfasst von Preyanate Wilairat und 7 weiteren Autor:innen. Beteiligte Einrichtung: The College of Pharmacotherapy of Thailand Nonthaburi Thailand. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The patterns of dual antiplatelet therapy (DAPT) use and the associated clinical outcomes in current practice remain limited. This study evaluates DAPT regimen patterns and clinical outcomes among acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI).

Methods

This multicenter retrospective cohort study included ACS patients treated with PCI from January 2017 to February 2022 at five tertiary hospitals in Thailand. DAPT was categorized as nonpotent (NP‐DAPT) or potent (P‐DAPT). We described DAPT trends, with major adverse cardiovascular events (MACEs) and major bleeding, as primary efficacy and safety outcomes. Outcomes were assessed using inverse probability treatment weighting (IPTW) with Cox's proportional hazards model.

Results

The study included 1877 patients with ACS undergoing PCI. The mean age was 64.51 years (standard deviation 11.34), with 639 (34.04%) female patients and 1159 (61.75%) presenting ST‐elevation myocardial infarction (STEMI). Of these, 924 (49.23%) received NP‐DAPT, and 953 (50.77%) were prescribed P‐DAPT. Crude MACE incidence was lower in the P‐DAPT compared to the NP‐DAPT group (6.82% vs. 10.28%). After applying IPTW and conducting Cox's proportional hazard analysis, no significant differences in MACE were observed between groups (hazard ratio [HR]: 0.85, 95% confidence interval [CI]: 0.58–1.25, p = 0.408), nor in major bleeding (HR: 0.80, 95% CI: 0.37–1.70, p = 0.555). P‐DAPT was associated with any higher bleeding risk (HR: 1.52, 95% CI: 1.13–2.03, p = 0.005).

Conclusion

Standard DAPT remains predominant among Thai ACS patients, with NP‐DAPT prescriptions approaching those of P‐DAPT. Despite similar rates of MACE and major bleeding between the groups, P‐DAPT was associated with a higher risk of any bleeding.

Schlagwörter

Stichwörter der Autor:innen

acute coronary syndromeclopidogreldual antiplatelet therapypercutaneous coronary interventionprasugrelprescription patternticagrelor

Autor:innen und Institutionen

  • The College of Pharmacotherapy of Thailand Nonthaburi Thailand.
  • Department of Pharmaceutical Care, Division of Pharmacy Practice, School of Pharmaceutical Sciences University of Phayao Phayao Thailand.
  • Department of Internal Medicine, Division of Cardiology Chiang Mai University Chiang Mai Thailand.
  • Center for Medical Excellence, Faculty of Medicine Chiang Mai University Chiang Mai Thailand.
  • Department of Internal Medicine Nakornping Hospital Chiang Mai Thailand.
  • Department of Pharmacy Chiangrai Regional Hospital Muang Chiangrai Thailand.

ORCID-Profile: Preyanate Wilairat, Arintaya Phrommintikul, Supharat Wattanasombat, Duangkamon Poolpun, Voratima Yoodee

Zitieren

APA

Wilairat, P., Phrommintikul, A., Chotayaporn, T., Wattanasombat, S., Hmuenpha, R., Kornjirakasemsan, S., Poolpun, D., & Yoodee, V. (2025). Trends in dual antiplatelet therapy regimens and clinical outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention with drug‐eluting stents: A multicenter real‐world study. Chronic Diseases and Translational Medicine, 11(1), 57-68. https://doi.org/10.1002/cdt3.154

Vancouver

Wilairat P, Phrommintikul A, Chotayaporn T, Wattanasombat S, Hmuenpha R, Kornjirakasemsan S, et al. Trends in dual antiplatelet therapy regimens and clinical outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention with drug‐eluting stents: A multicenter real‐world study. Chronic Diseases and Translational Medicine. 2025;11(1):57-68. doi:10.1002/cdt3.154

BibTeX
@article{Wilairat2025,
  author = {Wilairat, Preyanate and Phrommintikul, Arintaya and Chotayaporn, Thanyalak and Wattanasombat, Supharat and Hmuenpha, Rungtiwa and Kornjirakasemsan, Supitchaya and Poolpun, Duangkamon and Yoodee, Voratima},
  title = {Trends in dual antiplatelet therapy regimens and clinical outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention with drug‐eluting stents: A multicenter real‐world study},
  journal = {Chronic Diseases and Translational Medicine},
  year = {2025},
  volume = {11},
  number = {1},
  pages = {57--68},
  doi = {10.1002/cdt3.154}
}
Kostenlos starten →